Takeda to Spend $1.7 Billion Next Three Years Buying Drugs From Others
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical plans to spend about $1.7 billion over the next three years to buy new products from other companies. That amount is in addition to normal expenditures Takeda sets aside annually to purchase drugs made by others. (Click here for more